Clinical Trials
9
Active:2
Completed:1
Trial Phases
2 Phases
Phase 1:3
Phase 2:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (62.5%)Phase 1
3 (37.5%)A Phase 2 Study Using Aliya PEF Plus Pembro for Sarcoma
Phase 2
Withdrawn
- Conditions
- Soft Tissue Sarcoma
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Sarcoma Oncology Research Center, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT06494787
Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures
Withdrawn
- Conditions
- Sarcoma
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Sarcoma Oncology Research Center, LLC
- Registration Number
- NCT05869994
- Locations
- 🇺🇸
Sarcoma Oncology Research Center, Santa Monica, California, United States
GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma
Phase 2
Recruiting
- Conditions
- Sarcoma
- Interventions
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Sarcoma Oncology Research Center, LLC
- Target Recruit Count
- 260
- Registration Number
- NCT04535713
- Locations
- 🇺🇸
Sant P Chawla, Santa Monica, California, United States
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Sarcoma Oncology Research Center, LLC
- Target Recruit Count
- 80
- Registration Number
- NCT04535271
- Locations
- 🇺🇸
Sant P Chawla, Santa Monica, California, United States
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- Small Cell Lung CancerSolid Tumor, AdultSoft Tissue SarcomaNon Small Cell Lung Cancer
- Interventions
- Drug: AL3818
- First Posted Date
- 2019-11-15
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Sarcoma Oncology Research Center, LLC
- Target Recruit Count
- 56
- Registration Number
- NCT04165330
- Locations
- 🇺🇸
Sarcoma Oncology Research Center, Santa Monica, California, United States
- Prev
- 1
- 2
- Next
News
No news found